SLCO1A2
MOLECULAR TARGETsolute carrier organic anion transporter family member 1A2
SLCO1A2 (solute carrier organic anion transporter family member 1A2) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SLCO1A2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Thyroxine | 0.69 | 1 |
| 2 | naringin | 0.69 | 1 |
| 3 | Dehydroepiandrosterone Sulfate | 0.69 | 1 |
| 4 | Rifamycins | 0.69 | 1 |
| 5 | Rifamycins | 0.69 | 1 |
| 6 | Thyroxine | 0.69 | 1 |
| 7 | Triiodothyronine | 0.69 | 1 |
About SLCO1A2 as a Drug Target
SLCO1A2 (solute carrier organic anion transporter family member 1A2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented SLCO1A2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SLCO1A2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.